Table 2.

Percent of neutrophils, monocytes, and eosinophils of live leukocytes in circulation in E0771-GFP tumor-bearing C57BL/6 mice.

Day	% Neutrophils		% Monocytes		% Eosinophils
	Control	Ranitidine	Control	Ranitidine	Control	Ranitidine
0	9.75 ± 2.33	15.13 ± 2.01 (NS)	1.50 ± 0.54	4.13 ± 0.43**	0.88 ± 0.88	1.75 ± 0.43 (NS)
7	14.88 ± 3.22	15.13 ± 2.88 (NS)	4.75 ± 0.52	4.75 ± 0.60 (NS)	2.50 ± 0.54	2.63 ± 0.90 (NS)
14	13.13 ± 2.83	11.13 ± 4.32 (NS)	6.50 ± 1.14	5.50 ± 1.14 (NS)	2.25 ± 0.66	2.63 ± 0.59 (NS)
18	25.50 ± 4.26	24.38 ± 5.72 (NS)	4.25 ± 0.75	5.88 ± 0.80 (NS)	1.38 ± 0.43	2.38 ± 0.66 (NS)

NS, non-significant, **p < 0.01, Student’s unpaired t-test, N = 4.